Race against time to get breast cancer drug on the NHS

It’s Time for Trodelvy – Breast Cancer Now is making an urgent plea to the public to sign our open letter in a final bid to see a life-extending drug guaranteed on the NHS.

Last year we began campaigning around Trodelvy, an exciting new treatment for people living withincurable triple negative secondary breast cancer.

Trodelvy has the potential to provide hundreds of women with this life-limiting disease the hope of precious extra months spent with loved ones and doing what matters most to them.

On April 7, we received a devastating blow. The National Institute for Health and Care Excellence( NICE) provision ally rejected Trodelvy for routine use on the NHS in England due to the drug not being ‘costeffective’ – shattering the hope of patients in England who face the prospect of being denied this vital drug in the future, despite its approval in Scotland last month. This guidance for England will have knock on effects for patients in Wales and Northern Ireland too, where it’s likely NICE’s decision will be followed.

These women have no time to wait. This is why we’re asking readers to sign our open letter calling on the drug company Gilead, NICE and NHS England to find a solution – including Gilead pricing the drug fairly – so this life-extending drug is recommended for use on the NHS.

By adding your name to our open letter today you could help make all the difference to the hundreds of women in England who desperately need access to this drug and live in the hope of having more time. Behind this figure are daughters, sisters, mothers and friends, who face the frightening reality of limited treatment options and uncertainty about their future.

Ahead of the public consultation closing on April 29, we are doing all we can to ensure Trodelvy becomes routinely available on the NHS for patients who desperately need it.

This decision can be reversed – but we don’t have long, and we need your readers’ support.

Please sign our open letter now at action. breastcancernow.org/ trodelvy-sign-our-open-letter BARONESS DELYTH MORGAN Chief executive at Breast Cancer Now